2nd Quarter - Report

STUDENTS FOR SENSIBLE DRUG POLICY for STUDENTS FOR SENSIBLE DRUG POLICY

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Civil Rights/Civil Liberties CIV

Cannabis legalization and retroactive justice Psychedelic therapy & research Ending the War on Drugs

LobbyistCovered position, as disclosed
KAT MURTI New Executive Director

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); SENATE; Drug Enforcement Administration (DEA)

Alcohol and Drug Abuse ALC

Ending the War on Drugs Controlled Substance Act Scheduling

LobbyistCovered position, as disclosed
KAT MURTI New Executive Director

Contacted: Executive Office of the President (EOP); Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Preventing unscheduled research chemicals DOI and DOC from being added to Schedule I of the CSA

LobbyistCovered position, as disclosed
KAT MURTI Executive Director

Contacted: SENATE; Drug Enforcement Administration (DEA); Justice, Dept of (DOJ)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.